Table 2. Echocardiography of male mice treated with DOX.
WILD TYPE | Alpha-1A KO | |||||||
---|---|---|---|---|---|---|---|---|
Pre-DOX | Post-DOX | Pre-DOX | Post-DOX | |||||
Vehicle | A61603 | A6/Veh | Vehicle | A61603 | A6/Veh | |||
mice (n) | 13 | 7 | 6 | 12 | 4 | 8 | ||
FS (%) | 58 ± 4 | 49 ± 3 (12)++ | 61 ± 2 (14) | 1.20*** | 58 ± 1 | 38 ± 4+++ | 38 ± 4+++ | 0.99 |
LVIDd (mm) | 3.1 ± 0.1 | 2.5 ± 0.1+++ | 2.7 ± 0.1++ | 1.08 | 3.0 ± 0.1 | 2.3 ± 0.3+ | 2.3 ± 0.2++ | 0.98 |
LVIDs (mm) | 1.3 ± 0.1 | 1.4 ± 0.1 | 1.3 ± 0.1 | 0.89 | 1.2 ± 0.1 | 1.4 ± 0.1 | 1.4 ± 0.2 | 1.01 |
LVPWd (mm) | 0.9 ± 0.0 | 1.0 ± 0.1 | 0.9 ± 0.1 | 0.92 | 0.9 ± 0.0 | 1.1 ± 0.1 | 1.1 ± 0.1 | 1.02 |
LVPWs (mm) | 1.6 ± 0.1 | 1.2 ± 0.1++ | 1.4 ± 0.1 | 1.15 | 1.5 ± 0.0 | 1.1 ± 0.1++ | 1.3 ± 0.1++ | 1.12 |
IVSd (mm) | 0.9 ± 0.1 | 1.00 ± 0.1 | 0.9 ± 0.1 | 0.95 | 0.9 ± 0.0 | 0.9 ± 0.1 | 1.0 ± 0.1 | 1.05 |
IVSs (mm) | 1.7 ± 0.1 | 1.4 ± 0.1 | 1.6 ± 0.1 | 1.11 | 1.7 ± 0.0 | 1.4 ± 0.2+ | 1.4 ± 0.1+ | 1.06 |
SV (μV (±l) | 34 ± 1 | 17 ± 2+++ | 23 ± 3+++ | 1.37* | 31 ± 2 | 15 ± 1++ | 14 ± 3+++ | 0.74 |
HR (bpm) | 663 ± 12 | 300 ± 79+++ | 513 ± 77+ | 1.71* | 657 ± 11 | 252 ± 16+++ | 214 ± 47+++ | 0.85 |
CO (ml/min) | 22 ± 1 | 6 ± 2+++ | 13 ± 2+++ | 2.27** | 20 ± 1 | 4 ± 2+++ | 3 ± 1+++ | 0.79 |
CO/BW (ml/min/g) | 0.8 ± 0.0 | 0.2 ± 0.1+++ | 0.7 ± 0.1++ | 3.04*** | 0.8 ± 0.0 | 0.2 ± 0.1+++ | 0.1 ± 0.0+++ | 0.59 |
WT or alpha-1A-KO mice average age 16.5 weeks had DOX 25 mg/kg i.p., then were treated with A61603 10 ng/kg/d or Vehicle by mini-pump.
2D-guided M-mode echo was done Pre-DOX in some mice, and Post-DOX in all mice, either at euthanasia for HF or at 7 days.
Values are mean ± SE, with n (mice) given or in parentheses.
The n for Post-DOX FS is higher, since this was the only value recorded in an initial series of mice.
p by ANOVA with Newman-Keuls multiple comparisons test: A61603 vs. Vehicle
*** = <0.001
** = <0.01
* = <0.05
Post-DOX vs. Pre-DOX
+++ = <0.001
++ = <0.01
+ = <0.05.
Pre-DOX values for WT vs. alpha-1A-KO did not differ (p>0.1).